| Pneumococcal vaccination in high-risk individuals: are we doing it right? I Papadatou, V Spoulou Clinical and Vaccine Immunology 23 (5), 388-395, 2016 | 82 | 2016 |
| The role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects I Papadatou, I Tzovara, PV Licciardi Vaccines 7 (1), 13, 2019 | 46 | 2019 |
| Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries D Goldblatt, M Johnson, O Falup-Pecurariu, I Ivaskeviciene, V Spoulou, ... Journal of Hospital Infection 110, 60-66, 2021 | 35 | 2021 |
| Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal … I Papadatou, C Piperi, K Alexandraki, A Kattamis, M Theodoridou, ... Clinical infectious diseases 59 (6), 862-865, 2014 | 28 | 2014 |
| Case report: a novel synonymous ARPC1B gene mutation causes a syndrome of combined immunodeficiency, asthma, and allergy with significant intrafamilial clinical heterogeneity I Papadatou, N Marinakis, E Botsa, M Tzanoudaki, M Kanariou, I Orfanou, ... Frontiers in immunology 12, 634313, 2021 | 21 | 2021 |
| Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with β-thalassemia major I Papadatou, G Orthopoulos, M Theodoridou, V Spoulou Vaccine 33 (32), 3779-3783, 2015 | 17 | 2015 |
| Pneumococcal immunization strategies for high-risk pediatric populations worldwide: one size does not fit all T Lagousi, I Papadatou, P Strempas, E Chatzikalil, V Spoulou Vaccines 9 (12), 1390, 2021 | 10 | 2021 |
| Hematopoietic stem cell transplantation in ARPC1B deficiency S Giardino, S Volpi, F Lucioni, R Caorsi, J Schneiderman, A Lang, ... Journal of clinical immunology 42 (7), 1535-1544, 2022 | 8 | 2022 |
| Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with β-thalassemia: assessing the need for booster I Papadatou, T Lagousi, A Kattamis, V Spoulou Annals of Hematology 98, 775-779, 2019 | 8 | 2019 |
| Comparative characterization of human antibody response induced by BNT162b2 vaccination vs. SARS-CoV-2 wild-type infection T Lagousi, J Routsias, M Mavrouli, I Papadatou, M Geropeppa, V Spoulou Vaccines 10 (8), 1210, 2022 | 7 | 2022 |
| Epidemiology of community-acquired pneumonia hospitalizations and associated complications before and after the implementation of the heptavalent pneumococcal conjugate vaccine … T Lagousi, I Papadatou, I Kopsidas, E Critselis, M Theodoridou, ... Journal of the Pediatric Infectious Diseases Society 4 (3), 260-263, 2015 | 7 | 2015 |
| Pneumococcal vaccines: challenges and prospects P Licciardi, I Papadatou Vaccines 7 (1), 25, 2019 | 6 | 2019 |
| Paving the way towards precision vaccinology: the paradigm of myocarditis after coronavirus disease 2019 (COVID-19) vaccination T Lagousi, I Papadatou, P Strempas, E Chatzikalil, V Spoulou Clinical Infectious Diseases 75 (Supplement_1), S18-S23, 2022 | 4 | 2022 |
| Development of a novel flow cytometry method for detecting pneumococcal‐specific B cells I Tzovara, I Papadatou, M Tzanoudaki, V Spoulou Cytometry Part A 101 (7), 588-596, 2022 | 4 | 2022 |
| Receptor-binding-domain-specific B cell responses induced by mRNA immunization against SARS-CoV-2 M Geropeppa, I Papadatou, P Sarantis, M Tzanoudaki, ... Vaccines 11 (7), 1148, 2023 | 3 | 2023 |
| Targeting epigenetic mechanisms of resistance to chemotherapy in gliomas P Skouras, M Markouli, I Papadatou, C Piperi Critical Reviews in Oncology/Hematology, 104532, 2024 | 2 | 2024 |
| SARS-CoV-2 MRNA Dual Immunization Induces Innate Transcriptional Signatures, Establishes T-Cell Memory and Coordinates the Recall Response I Papadatou, M Geropeppa, KM Verrou, M Tzanoudaki, T Lagousi, ... Vaccines 11 (1), 103, 2023 | 2 | 2023 |
| Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature P Tsagkli, M Geropeppa, I Papadatou, V Spoulou Vaccines 12 (9), 1051, 2024 | 1 | 2024 |
| Immunogenicity, Immunological Memory and monitoring of disease activity following an anamnestic immunization with the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in … K Kitsou, V Askiti, M Tzanoudaki, A Mitsioni, I Papadatou, E Liatsis, ... Journal of the Pediatric Infectious Diseases Society, piae057, 2024 | 1 | 2024 |
| The Divergent Effect of Different Infant Vaccination Schedules of the 13-Valent Pneumococcal Conjugate Vaccine on Serotype-Specific Immunological Memory I Tzovara, I Papadatou, M Tzanoudaki, C Piperi, C Kanaka-Gantenbein, ... Vaccines 12 (9), 1024, 2024 | | 2024 |
